Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases

Pharmacology and Therapeutics

Volumn 177, Issue , 2017, Pages 44-55

  Byun, Kyunghee ^a   Yoo, YongCheol ^b   Son, Myeongjoo ^a   Lee, Jaesuk ^a   Jeong, Goo Bo ^a   Park, Young Mok ^b   Salekdeh, Ghasem Hosseini ^c   Lee, Bonghee ^a  

^a Gachon University   (South Korea)

^b Institute for Basic Science   (South Korea)

^c ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

Advanced glycation end products (AGEs); Degenerative diseases; Inflammation; Macrophage; Receptor for AGEs (RAGE)

Indexed keywords

ACUTE PHASE PROTEIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR ANTAGONIST; AMINOGUANIDINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; ATORVASTATIN; CARNOSINE; CHEMOKINE; CURCUMIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIGAND; METFORMIN; NITRIC OXIDE; OXYGEN RADICAL; PROSTAGLANDIN; PYRIDOXAMINE; QUERCETIN; RESVERATROL; SERINE PROTEINASE; TELMISARTAN; THIOCTIC ACID; UNINDEXED DRUG; VITAMIN D;

ACUTE HEART INFARCTION; ALCOHOLISM; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; CARDIAC MUSCLE CELL; DEGENERATIVE DISEASE; DIABETIC COMPLICATION; DIABETIC NEPHROPATHY; FIBROSING ALVEOLITIS; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; KIDNEY TUBULE CELL; LIVER CELL; LIVER CIRRHOSIS; LUNG ALVEOLUS EPITHELIUM CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; NERVE CELL NECROSIS; NONHUMAN; OSTEOARTHRITIS; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; METABOLISM;

GLYCATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; MACROPHAGES; NEURODEGENERATIVE DISEASES; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS;

EID: 85014995461     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2017.02.030     Document Type: Review

References (187)

1. Abdelsalam, R.M., Safar, M.M., Safar neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: Role of RAGE-NFκB and Nrf2-antioxidant signaling pathways. Journal of Neurochemistry 133 (2015), 700–707.
2. Abdul, H.M., Butterfield, D.A., Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Free Radical Biology & Medicine 42 (2007), 371–384.
3. Abe, R., Shimizu, T., Sugawara, H., Watanabe, H., Nakamura, H., Choei, H., et al. Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions. The Journal of Investigative Dermatology 122 (2004), 461–467.
4. Adrover, M., Vilanova, B., Frau, J., Muñoz, F., Donoso, J., The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect. Bioorganic & Medicinal Chemistry 16 (2008), 5557–5569.
5. Ahmad, M.S., Ahmed, N., Antiglycation properties of aged garlic extract: Possible role in prevention of diabetic complications. The Journal of Nutrition 136 (2006), 796S–799S.
6. Ahn, S.M., Byun, K., Cho, K., Kim, J.Y., Yoo, J.S., Kim, D., et al. Human microglial cells synthesize albumin in brain. PloS One, 3, 2008, e2829.
7. Ajith, T.A., Harikumar, K.B., Thasna, H., Sabu, M.C., Babitha, N.V., Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice. Clinica Chimica Acta 366 (2006), 322–328.
8. Ajith, T.A., Riji, T., Anu, V., In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin. Clinical and Experimental Pharmacology & Physiology 35 (2008), 625–629.
9. Aleshin, A., Ananthakrishnan, R., Li, Q., Rosario, R., Lu, Y., Qu, W., et al. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model. American Journal of Physiology. Heart and Circulatory Physiology 294 (2008), H1823–H1832.
10. Aliev, G., Palacios, H.H., Gasimov, E., Obrenovich, M.E., Morales, L., Leszek, J., et al. Oxidative stress induced mitochondrial failure and vascular hypoperfusion as a key initiator for the development of Alzheimer disease. Pharmaceuticals (Basel) 3 (2010), 158–187.
11. Andrassy, M., Volz, H.C., Igwe, J.C., Funke, B., Eichberger, S.N., Kaya, Z., et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117 (2008), 3216–3226.
12. Ansari, N.A., Dash, D., Amadori glycated proteins: Role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. Aging and Disease 4 (2013), 50–56.
13. Arsov, S., Graaff, R., van Oeveren, W., Stegmayr, B., Sikole, A., Rakhorst, G., et al. Advanced glycation end-products and skin autofluorescence in end-stage renal disease: A review. Clinical Chemistry and Laboratory Medicine 52 (2014), 11–20.
14. Ashraf, J.M., Shahab, U., Tabrez, S., Lee, E.J., Choi, I., Ahmad, S., Quercetin as a finer substitute to aminoguanidine in the inhibition of glycation products. International Journal of Biological Macromolecules 77 (2015), 188–192.
15. Bayarsaikhan, E., Bayarsaikhan, D., Lee, J., Son, M., Oh, S., Moon, J., et al. Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: A possible implication for theranostics. International Journal of Nanomedicine 23:Spec Iss (2016), 281–292.
16. Bertheloot, D., Latz, E., HMGB1, IL-1α, IL-33 and S100 proteins: Dual-function alarmins. Cellular & Molecular Immunology 13 (2016), 1–22.
17. Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., et al. Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells. Diabetes 46 (1997), 1481–1490.
18. Bierhaus, A., Hofmann, M.A., Ziegler, R., Nawroth, P.P., AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovascular Research 37 (1998), 586–600.
19. Blanco, F.J., López-Armada, M.J., Maneiro, E., Mitochondrial dysfunction in osteoarthritis. Mitochondrion 4 (2004), 715–728.
20. Bolton, W.K., Cattran, D.C., Williams, M.E., Adler, S.G., Appel, G.B., Cartwright, K., et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. American Journal of Nephrology 24 (2004), 32–40.
21. Borsi, V., Cerofolini, L., Fragai, M., Luchinat, C., NMR characterization of the C-terminal tail of full-length RAGE in a membrane mimicking environment. Journal of Biomolecular NMR 54 (2012), 285–290.
22. Bortolotto, V., Grilli, M., Every cloud has a silver lining: Proneurogenic effects of Aβ oligomers and HMGB-1 via activation of the RAGE-NF-κB axis. CNS & Neurological Disorders Drug Targets 15 (2016), 1–14.
23. Brass, L.F., Molino, M., Protease-activated G protein-coupled receptors on human platelets and endothelial cells. Thrombosis and Haemostasis 78 (1997), 234–241.
24. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., Cerami, A., Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232 (1986), 1629–1632.
25. Burillo, E., Recalde, D., Jarauta, E., Fiddyment, S., Garcia-Otin, A.L., Mateo-Gallego, R., et al. Proteomic study of macrophages exposed to oxLDL identifies a CAPG polymorphism associated with carotid atherosclerosis. Atherosclerosis 207 (2009), 32–37.
26. Byun, K., Bayarsaikhan, E., Kim, D., Kim, C.Y., Mook-Jung, I., Paek, S.H., et al. Induction of neuronal death by microglial AGE-albumin: Implications for Alzheimer's disease. PloS One, 7, 2012, e37917.
27. Byun, K., Bayarsaikhan, E., Kim, D., Son, M., Hong, J., Jeong, G.B., et al. Activated microglial cells synthesize and secrete AGE-albumin. Anatomy and Cell Biology 45 (2012), 47–52.
28. Byun, K., Bayarsaikhan, D., Bayarsaikhan, E., Son, M., Oh, S., Lee, J., et al. Microglial AGE-albumin is critical in promoting alcohol-induced neurodegeneration in rats and humans. PloS One, 9, 2014, e104699.
29. Chavakis, T., Bierhaus, A., Nawroth, P.P., RAGE (receptor for advanced glycation end products): A central player in the inflammatory response. Microbes and Infection 6 (2004), 1219–1225.
30. Chen, S., Yin, L., Xu, Z., An, F.M., Liu, A.R., Wang, Y., et al. Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis. Neuroscience Letters 612 (2016), 193–198.
31. Cheng, M., Liu, H., Zhang, D., Liu, Y., Wang, C., Liu, F., Chen, J., HMGB1 enhances the AGE-induced expression of CTGF and TGF-β via RAGE-dependent signaling in renal tubular epithelial cells. American Journal of Nephrology 41 (2015), 257–266.
32. Cheng, Y., Wang, H., Mao, M., Liang, C., Zhang, Y., Yang, D., et al. Escin increases the survival rate of LPS-induced septic mice through inhibition of HMGB1 release from macrophages. Cellular Physiology and Biochemistry 36 (2015), 1577–1586.
33. Crews, F.T., Vetreno, R.P., Neuroimmune basis of alcoholic brain damage. International Review of Neurobiology 118 (2014), 315–357.
34. Crews, F.T., Vetreno, R.P., Mechanisms of neuroimmune gene induction in alcoholism. Psychopharmacology 233 (2016), 1543–1557.
35. De Vijlder, J.J., Veenboer, G.J., van Dijk, J.E., Thyroid albumin originates from blood. Endocrinology 131 (1992), 578–584.
36. Deng, Y., Yang, Z., Gao, Y., Xu, H., Zheng, B., Jiang, M., et al. Toll-like receptor 4 mediates acute lung injury induced by high mobility group box-1. PloS One, 8, 2013, e64375.
37. Dhumale, S.S., Waghela, B.N., Pathak, C., Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells. IUBMB Life 67 (2015), 361–373.
38. Di Filippo, C., Cuzzocrea, S., Rossi, F., Marfella, R., D'Amico, M., Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovascular Drug Reviews 24 (2006), 77–87.
39. Dias, V., Junn, E., Mouradian, M.M., The role of oxidative stress in Parkinson's disease. Journal of Parkinson's Disease 3 (2013), 461–491.
40. Donato, R., Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochimica et Biophysica Acta 1450 (1999), 191–231.
41. Donato, R., RAGE: A single receptor for several ligands and different cellular responses: The case of certain S100 proteins. Current Molecular Medicine 7 (2007), 711–724.
42. Dong, H., Li, J., Lv, Y., Zhou, Y., Wang, G., Hu, S., et al. Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase. BMC Immunology 17 (2013), 14–25.
43. Elfeky, M., Kaede, R., Okamatsu-Ogura, Y., Kimura, K., Adiponectin inhibits LPS-induced HMGB1 release through an AMP kinase and Heme oxygenase-1-dependent pathway in RAW 264 macrophage cells. Mediators of Inflammation, 2016, 2016, 5701959.
44. Fang, F., Lue, L.F., Yan, S., Xu, H., Luddy, J.S., Chen, D., et al. RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. The FASEB Journal 24 (2010), 1043–1055.
45. Farris, S.D., Hu, J.H., Krishnan, R., Emery, I., Chu, T., Du, L., et al. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: Role of the uPA receptor and S100A8/A9 proteins. The Journal of Biological Chemistry 286 (2011), 22665–22677.
46. Feng, B., Xu, L., Wang, H., Yan, X., Xue, J., Liu, F., et al. Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products. Biochimica et Biophysica Acta 1812 (2011), 1130–1137.
47. Figarola, J.L., Shanmugam, N., Natarajan, R., Rahbar, S., Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes 56 (2007), 647–655.
48. Freeburn, R.W., Armstrong, L., Millar, A.B., Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions. European Cytokine Network 16 (2005), 5–16.
49. Freedman, B.I., Wuerth, J.P., Cartwright, K., Bain, R.P., Dippe, S., Hershon, K., et al. Design and baseline characteristics for the aminoguanidine clinical trial in overt type 2 diabetic nephropathy (ACTION II). Controlled Clinical Trials 20 (1999), 493–510.
50. Freiwald, A., Weidner, C., Witzke, A., Huang, S.Y., Meierhofer, D., Sauer, S., Comprehensive proteomic data sets for studying adipocyte-macrophage cell-cell communication. Proteomics 13 (2013), 3424–3428.
51. Ge, J., Jia, Q., Liang, C., Luo, Y., Huang, D., Sun, A., et al. Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arteriosclerosis, Thrombosis, and Vascular Biology 25 (2005), 2157–2163.
52. Gensel, J.C., Zhang, B., Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Research 1619 (2015), 1–11.
53. Gkogkolou, P., Böhm, M., Advanced glycation end products: Key players in skin aging?. Dermatoendocrinology 4 (2012), 259–270.
54. Goldin, A., Beckman, J.A., Schmidt, A.M., Creager, M.A., Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 114 (2006), 597–605.
55. Gosse, P., Schumacher, H., Effect of telmisartan vs. ramipril on ‘dipping’ status and blood pressure variability: Pooled analysis of the PRISMA studies. Hypertension Research 37 (2014), 151–157.
56. Gross, S.R., Sin, C.G., Barraclough, R., Rudland, P.S., Joining S100 proteins and migration: For better or for worse, in sickness and in health. Cellular and Molecular Life Sciences 71 (2014), 1551–1579.
57. Gruys, E., Toussaint, M.J., Niewold, T.A., Koopmans, S.J., Acute phase reaction and acute phase proteins. Journal of Zhejiang University. Science. B 6 (2005), 1045–1056.
58. Guiotto, A., Calderan, A., Ruzza, P., Borin, G., Carnosine and carnosine-related antioxidants: A review. Current Medicinal Chemistry 12 (2005), 2293–2315.
59. Hagiwara, S., Iwasaka, H., Matumoto, S., Hidaka, S., Noguchi, T., Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Critical Care Medicine 37 (2009), 626–633.
60. He, M., Kubo, H., Ishizawa, K., Hegab, A.E., Yamamoto, Y., Yamamoto, H., et al. The role of the receptor for advanced glycation end-products in lung fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology 293 (2007), L1427–L1436.
61. He, M., Kubo, H., Morimoto, K., Fujino, N., Suzuki, T., Takahasi, T., et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Reports 12 (2011), 358–364.
62. Heneka, M.T., O'Banion, M.K., Terwel, D., Kummer, M.P., Neuroinflammatory processes in Alzheimer's disease. Journal of Neural Transmission (Vienna) 117 (2010), 919–947.
63. Hernanz, R., Briones, A.M., Alonso, M.J., Vila, E., Salaices, M., Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries. American Journal of Physiology. Heart and Circulatory Physiology 287 (2004), H225–H234.
64. Herzog, C., Lorenz, A., Gillmann, H.J., Chowdhury, A., Larmann, J., Harendza, T., et al. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling. Cardiovascular Research 101 (2014), 400–410.
65. Hirohashi, N., Morrison, D.C., Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infection and Immunity 64 (1996), 1011–1015.
66. Hofmann, M.A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., et al. RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides. Cell 97 (1999), 889–901.
67. Huttunen, H.J., Fages, C., Rauvala, H., Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. The Journal of Biological Chemistry 274 (1999), 19919–19924.
68. Jain, S., Gautam, V., Naseem, S., Acute-phase proteins: As diagnostic tool. Journal of Pharmacy & Bioallied Sciences 3 (2011), 118–127.
69. Jinnouchi, Y., Yamagishi, S., Takeuchi, M., Ishida, S., Jinnouchi, Y., Jinnouchi, J., et al. Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes. Clinical and Experimental Medicine 6 (2006), 191–193.
70. Jirillo, E., Caccavo, D., Magrone, T., Piccigallo, E., Amati, L., Lembo, A., et al. The role of the liver in the response to LPS: Experimental and clinical findings. Journal of Endotoxin Research 8 (2002), 319–327.
71. Joglekar, M.M., Panaskar, S.N., Arvindekar, A.U., Inhibition of advanced glycation end product formation by cymene–A common food constituent. Journal of Functional Foods 6 (2014), 107–115.
72. Jono, T., Kimura, T., Takamatsu, J., Nagai, R., Miyazaki, K., Yuzuriha, T., et al. Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl) lysine in hippocampal CA4 pyramidal neurons of aged human brain. Pathology International 52 (2002), 563–571.
73. Joshi, D., Gupta, R., Dubey, A., Shiwalkar, A., Pathak, P., Gupta, R.C., et al. TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes. Journal of Cardiovascular Pharmacology 54 (2009), 72–81.
74. Kalinina, N., Agrotis, A., Antropova, Y., DiVitto, G., Kanellakis, P., Kostolias, G., et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: Role of activated macrophages and cytokines. Arteriosclerosis, Thrombosis, and Vascular Biology 24 (2004), 2320–2325.
75. Kang, J.H., Kim, H.T., Choi, M.S., Lee, W.H., Huh, T.L., Park, Y.B., et al. Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics 6 (2006), 1261–1273.
76. Kao, Y.H., Lin, Y.C., Tsai, M.S., Sun, C.K., Yuan, S.S., Chang, C.Y., et al. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis. Biochimica et Biophysica Acta 1842 (2014), 1720–1732.
77. Karumanchi, D.K., Karunaratne, N., Lurio, L., Dillon, J.P., Gaillard, E.R., Non-enzymatic glycation of α-crystallin as an in vitro model for aging, diabetes and degenerative diseases. Amino Acids 47 (2015), 2601–2608.
78. Kikuchi, K., Uchikado, H., Miura, N., Morimoto, Y., Ito, T., Tancharoen, S., et al. HMGB1 as a therapeutic target in spinal cord injury: A hypothesis for novel therapy development. Experimental and Therapeutic Medicine 2 (2011), 767–770.
79. Kim, Y.S., Joh, T.H., Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson's disease. Experimental & Molecular Medicine 38 (2006), 333–347.
80. Kim, J.M., Han, H.J., Hur, Y.H., Quan, H., Kwak, S.H., Choi, J.I., et al. Stearoyl lysophosphatidylcholine prevents lipopolysaccharide-induced extracellular release of high mobility group box-1 through AMP-activated protein kinase activation. International Immunopharmacology 28 (2015), 540–545.
81. Kim, S.W., Jin, Y., Shin, J.H., Kim, I.D., Lee, H.K., Park, S., et al. Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiology of Disease 46 (2012), 147–156.
82. Kim, J.B., Lim, C.M., Yu, Y.M., Lee, J.K., Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. Journal of Neuroscience Research 86 (2008), 1125–1131.
83. Kobayashi, R., Tashima, Y., Purification, biological properties and partial sequence analysis of 67-kDa calcimedin and its 34-kDa fragment from chicken gizzard. European Journal of Biochemistry 188 (1990), 447–453.
84. Kobayashi, R., Deavers, M., Patenia, R., Rice-Stitt, T., Halbe, J., Gallardo, S., et al. 14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients. Cancer Immunology, Immunotherapy 58 (2009), 247–258.
85. Kokkola, R., Sundberg, E., Ulfgren, A.K., Palmblad, K., Li, J., Wang, H., et al. High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis. Arthritis and Rheumatism 46 (2002), 2598–2603.
86. Kraft, A.D., Harry, G.J., Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. International Journal of Environmental Research and Public Health 8 (2011), 2980–3018.
87. Kratz, M., Coats, B.R., Hisert, K.B., Hagman, D., Mutskov, V., Peris, E., et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metabolism 20 (2014), 614–625.
88. Krautwald, M., Leech, D., Horne, S., Steele, M.L., Forbes, J., Rahmadi, A., et al. The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase. Rejuvenation Research 14 (2011), 383–391.
89. Kuhla, A., Trieglaff, C., Vollmar, B., Role of age and uncoupling protein-2 in oxidative stress, RAGE/AGE interaction and inflammatory liver injury. Experimental Gerontology 46 (2011), 868–876.
90. Kurien, B.T., Scofield, R.H., Autoimmunity and oxidatively modified autoantigens. Autoimmunity Reviews 7 (2008), 567–573.
91. Lane, R.K., Hilsabeck, T., Rea, S.L., The role of mitochondrial dysfunction in age-related diseases. Biochimica et Biophysica Acta 1847 (2015), 1387–1400.
92. Lee, S.-J., Lee, K.-W., Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells. Biol Pharm Bull 30:8 (2007), 1369–1373.
93. Lee, J.Y., Oh, J.G., Kim, J.S., Lee, K.W., Effects of chebulic acid on advanced glycation endproducts-induced collagen cross-links. Biological & Pharmaceutical Bulletin 37 (2014), 1162–1167.
94. Legler, D.F., Bruckner, M., Uetz-von Allmen, E., Krause, P., Prostaglandin E2 at new glance: Novel insights in functional diversity offer therapeutic chances. The International Journal of Biochemistry & Cell Biology 42 (2010), 198–201.
95. Li, Y., Takemura, G., Kosai, K.I., Takahashi, T., Okada, H., Miyata, S., et al. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circulation Research 95 (2004), 627–636.
96. Liesz, A., Dalpke, A., Mracsko, E., Antoine, D.J., Roth, S., Zhou, W., et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. The Journal of Neuroscience 35 (2015), 583–598.
97. Lietzén, N., Ohman, T., Rintahaka, J., Julkunen, I., Aittokallio, T., Matikainen, S., et al. Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages. PLoS Pathogens, 7, 2011, e1001340.
98. Limongi, D., Baldelli, S., Redox imbalance and viral infections in neurodegenerative diseases. Oxidative Medicine and Cellular Longevity, 2016, 2016, 6547248.
99. Luevano-Contreras, C., Chapman-Novakofski, K., Dietary advanced glycation end products and aging. Nutrients 2 (2010), 1247–1265.
100. Lv, C., Wang, L., Liu, X., Cong, X., Yan, S.S., Wang, Y., et al. Geniposide attenuates oligomeric Aβ(1-42)-induced inflammatory response by targeting RAGE-dependent signaling in BV2 cells. Current Alzheimer Research 11 (2014), 430–440.
101. Ma, Y., Bao, J., Zhao, X., Shen, H., Lv, J., Ma, S., et al. Activated cyclin-dependent kinase 5 promotes microglial phagocytosis of fibrillar β-amyloid by up-regulating lipoprotein lipase expression. Molecular & Cellular Proteomics 12 (2013), 2833–2844.
102. Macdonald, J., Galley, H.F., Webster, N.R., Oxidative stress and gene expression in sepsis. British Journal of Anaesthesia 90 (2003), 221–232.
103. Mahali, S., Raviprakash, N., Raghavendra, P.B., Manna, S.K., Advanced glycation end products (AGEs) induce apoptosis via a novel pathway: Involvement of Ca2 + mediated by interleukin-8 protein. The Journal of Biological Chemistry, 286, 2011 (34903-34013).
104. Maltais, J.S., Simard, E., Froehlich, U., Denault, J.B., Gendron, L., Grandbois, M., iRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells. Pharmacological Research 104 (2016), 176–185.
105. Matsui, T., Nakamura, N., Ojima, A., Nishino, Y., Yamagishi, S.I., Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta. Nutrition, Metabolism, and Cardiovascular Diseases 26 (2016), 797–807.
106. Matsuki, K., Tamasawa, N., Yamashita, M., Tanabe, J., Murakami, H., Matsui, J., et al. Metformin restores impaired HDL-mediated cholesterol efflux due to glycation. Atherosclerosis 206 (2009), 434–438.
107. Mayer, B., John, M., Böhme, E., Purification of a Ca2 +/calmodulin-dependent nitric oxide synthase from porcine cerebellum. FEBS Letters 277 (1990), 215–219.
108. McCormick, M.M., Rahimi, F., Bobryshev, Y.V., Gaus, K., Zreiqat, H., Cai, H., et al. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. Journal of Biological Chemistry 280 (2005), 41521–41529.
109. Miettinen, J.J., Matikainen, S., Nyman, T.A., Global secretome characterization of herpes simplex virus 1-infected human primary macrophages. Journal of Virology 86 (2012), 12770–12778.
110. Miles, P.R., Bowman, L., Rao, K.M., Baatz, J.E., Huffman, L., Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. The American Journal of Physiology 276 (1999), L186–L196.
111. Miyazaki, A., Nakayama, H., Horiuchi, S., Scavenger receptors that recognize advanced glycation end products. Trends in Cardiovascular Medicine 12 (2002), 258–262.
112. Mizutani, K., Ikeda, K., Yamori, Y., Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Biochemical and Biophysical Research Communications 274 (2000), 61–67.
113. Mortaz, E., Adcock, I.M., Ricciardolo, F.L., Varahram, M., Jamaati, H., Velayati, A.A., et al. Anti-inflammatory effects of Lactobacillus rahmnosus and Bifidobacterium breve on cigarette smoke activated human macrophages. PloS One, 10, 2015, e0136455.
114. Müller, G., Heizmann, C.W., Albumin in chicken skeletal muscle. European Journal of Biochemistry 123 (1982), 577–582.
115. Nahon, J.L., Tratner, I., Poliard, A., Presse, F., Poiret, M., Gal, A., et al. Albumin and alpha-fetoprotein gene expression in various nonhepatic rat tissues. The Journal of Biological Chemistry 263 (1988), 11436–11442.
116. Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Ueda, Y., Suzuki, T., et al. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients. Metabolism 58 (2009), 1624–1628.
117. Nakashima, K., Miyashita, H., Yoshimitsu, H., Fujiwara, Y., Nagai, R., Ikeda, T., Two new prenylflavonoids from Epimedii herba and their inhibitory effects on advanced glycation end-products. Journal of Natural Medicines 70 (2016), 290–295.
118. Nakashima, M., Sakai, T., Hiraiwa, H., Hamada, T., Omachi, T., Ono, Y., et al. Role of S100A12 in the pathogenesis of osteoarthritis. Biochemical and Biophysical Research Communications 422 (2012), 508–514.
119. Nienhuis, H.L., Westra, J., Smit, A.J., Limburg, P.C., Kallenberg, C.G., Bijl, M., AGE and their receptor RAGE in systemic autoimmune diseases: An inflammation propagating factor contributing to accelerated atherosclerosis. Autoimmunity 42 (2009), 302–304.
120. Nystedt, S., Ramakrishnan, V., Sundelin, J., The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells comparison with the thrombin receptor. The Journal of Biological Chemistry 271 (1996), 14910–14915.
121. Origlia, N., Bonadonna, C., Rosellini, A., Leznik, E., Arancio, O., Yan, S.S., et al. Microglial receptor for advanced glycation end product-dependent signal pathway drives β-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex. The Journal of Neuroscience 30 (2010), 11414–11425.
122. Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., Simm, A., Role of advanced glycation end products in cellular signaling. Redox Biology 2 (2014), 411–429.
123. Rahman, I., The role of oxidative stress in the pathogenesis of COPD. Treatments in Respiratory Medicine 4 (2005), 175–200.
124. Ramasamy, R., Yan, S.F., Schmidt, A.M., Advanced glycation endproducts: From precursors to RAGE: Round and round we go. Amino Acids 42 (2012), 1151–1161.
125. Rammes, A., Roth, J., Goebeler, M., Klempt, M., Hartmann, M., Sorg, C., Myeloidrelated protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. The Journal of Biological Chemistry 272 (1997), 9496–9502.
126. Reynolds, A.D., Glanzer, J.G., Kadiu, I., Ricardo-Dukelow, M., Chaudhuri, A., Ciborowski, P., et al. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. Journal of Neurochemistry 104 (2008), 1504–1525.
127. Reynolds, P.R., Kasteler, S.D., Cosio, M.G., Sturrock, A., Huecksteadt, T., Hoidal, J.R., RAGE: Developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 294 (2008), L1094–L1101.
128. Ricciotti, E., FitzGerald, G.A., Prostaglandins and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 31 (2011), 986–1000.
129. Ritchie, R.F., Palomaki, G.E., Neveux, L.M., Navolotskaia, O., Ledue, T.B., Craig, W.Y., Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: A practical, simple and clinically relevant approach in a large cohort. Journal of Clinical Laboratory Analysis 13 (1999), 273–279.
130. Rolo, A.P., Palmeira, C.M., Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicology and Applied Pharmacology 212 (2006), 167–178.
131. Russo, I., Frangogiannis, N.G., Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. Journal of Molecular and Cellular Cardiology 90 (2016), 84–93.
132. Ryan, B.J., Nissim, A., Winyard, P.G., Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases. Redox Biology 28 (2014), 715–724.
133. Saïd-Sadier, N., Ojcius, D.M., Alarmins, inflammasomes and immunity. Biomedical Journal 35 (2012), 437–449.
134. Salum, E., Kals, J., Kampus, P., Salum, T., Zilmer, K., Aunapuu, M., et al. Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats. Diabetes Research and Clinical Practice 100 (2013), 243–249.
135. Sathe, K., Maetzler, W., Lang, J.D., Mounsey, R.B., Fleckenstein, C., Martin, H.L., et al. S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway. Brain 135 (2012), 3336–3347.
136. Schmidt, A.M., Du Yan, S., Yan, S.F., Stern, D.M., The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. The Journal of Clinical Investigation 108 (2001), 949–955.
137. Seeliger, S., Vogl, T., Engels, I.H., Schröder, J.M., Sorg, C., Sunderkötter, C., et al. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. The American Journal of Pathology 163 (2003), 947–956.
138. Shin, J.H., Lee, H.K., Lee, H.B., Jin, Y., Lee, J.K., Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain. Neuroscience Letters 558 (2014), 159–163.
139. Simm, A., Wagner, J., Gursinsky, T., Nass, N., Friedrich, I., Schinzel, R., et al. Advanced glycation endproducts: A biomarker for age as an outcome predictor after cardiac surgery?. Experimental Gerontology 42 (2007), 668–675.
140. Singh, R., Barden, A., Mori, T., Beilin, L., Advanced glycation end-products: A review. Diabetologia 44 (2001), 129–146.
141. Singhto, N., Sintiprungrat, K., Thongboonkerd, V., Alterations in macrophage cellular proteome induced by calcium oxalate crystals: The association of HSP90 and F-actin is important for phagosome formation. Journal of Proteome Research 12 (2013), 3561–3572.
142. Son, S.M., Jung, E.S., Shin, H.J., Byun, J., Mook-Jung, I., Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling. Neurobiology of Aging 33 (2012), 1006.e11–1006.e23.
143. Song, B.J., Akbar, M., Abdelmegeed, M.A., Byun, K., Lee, B., Yoon, S.K., et al. Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biology 3 (2014), 109–123.
144. Song, J.S., Kang, C.M., Park, C.K., Yoon, H.K., Lee, S.Y., Ahn, J.H., et al. Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transition. Experimental & Molecular Medicine 43 (2011), 517–524.
145. Srikanth, V., Maczurda, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiology of Aging 32 (2011), 763–777.
146. Steinhoff, M., Buddenkotte, J., Shpacovitch, V., Rattenholl, A., Moormann, C., Vergnolle, N., et al. Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response. Endocrine Reviews 26 (2005), 1–43.
147. Stern, D., Yan, S.D., Yan, S.F., Schmidt, A.M., Receptor for advanced glycation endproducts: A multiligand receptor magnifying cell stress in diverse pathologic settings. Advanced Drug Delivery Reviews 54 (2002), 1615–1625.
148. Sugihara, Y., Nojima, H., Matsuda, H., Murakami, T., Yoshikawa, M., Kimura, I., Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptozotocin-diabetic mice. Journal of Asian Natural Products Research 2 (2000), 321–327.
149. Takeuchi, M., Yamagishi, S., TAGE (toxic AGEs) hypothesis in various chronic diseases. Medical Hypotheses 63 (2004), 449–452.
150. Takeuchi, M., Takino, J.I., Yamagishi, S.I., Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: A novel therapeutic strategy. Current Drug Targets 11 (2010), 1468–1482.
151. Tam, H.L., Shiu, S.W., Wong, Y., Chow, W.S., Betteridge, D.J., Tan, K.C., Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes. Atherosclerosis 209 (2010), 173–177.
152. Tang, Y., Curcumin eliminates the effect of advanced glycation endproducts (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling. Laboratory Investigation 94 (2014), 503–516.
153. Teismann, P., Sathe, K., Bierhaus, A., Leng, L., Martin, H.L., Bucala, R., et al. Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. Neurobiology of Aging 33 (2012), 2478–2490.
154. Terada, C., Yoshida, A., Nasu, Y., Mori, S., Tomono, Y., Tanaka, M., et al. Gene expression and localization of high-mobility group box chromosomal protein-1 (HMGB-1) in human osteoarthritic cartilage. Acta Medica Okayama 65 (2011), 369–377.
155. Tessier, F., Obrenovich, M., Monnier, V.M., Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis. The Journal of Biological Chemistry 274 (1999), 20796–20804.
156. Thomas, M.C., Tikellis, C., Burns, W.M., Bialkowski, K., Cao, Z., Coughlan, M.T., et al. Interactions between renin angiotensin system and advanced glycation in the kidney. Journal of the American Society of Nephrology 16 (2005), 2976–2984.
157. Tian, S., Zhang, L., Tang, J., Guo, X., Dong, K., Chen, S.Y., HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the early stage of obstructive injury. American Journal of Physiology. Renal Physiology 308 (2015), F69–F75.
158. Tsoporis, J.N., Izhar, S., Leong-Poi, H., Desjardins, J.F., Huttunen, H.J., Parker, T.G., S100B interaction with the receptor for advanced glycation end products (RAGE): A novel receptor-mediated mechanism for myocyte apoptosis postinfarction. Circulation Research 106 (2010), 93–101.
159. van Lent, P.L., Blom, A.B., Schelbergen, R.F., Slöetjes, A., Lafeber, F.P., Lems, W.F., et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis and Rheumatism 64 (2012), 1466–1476.
160. Varol, C., Mildner, A., Jung, S., Macrophages: Development and tissue specialization. Annual Review of Immunology 33 (2015), 643–675.
161. Vasan, S., Foiles, P.G., Founds, H.W., Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links. Expert Opinion on Investigational Drugs 10 (2001), 1977–1987.
162. Wallace, J.L., Nitric oxide as a regulator of inflammatory processes. Memórias do Instituto Oswaldo Cruz 100 (2005), 5–9.
163. Wang, C.Y., Xie, J.W., Xu, Y., Wang, T., Cai, J.H., Wang, X., et al. Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease. Antioxidants & Redox Signaling 19 (2013), 2024–2039.
164. Wang, X., Yu, S., Hu, J.P., Wang, C.Y., Wang, Y., Liu, H.X., et al. Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway. The International Journal of Neuroscience 124 (2014), 601–608.
165. Wang, L., Zhang, X., Liu, L., Yang, R., Cui, L., Li, M., Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression. Neuroscience Letters 471 (2010), 152–156.
166. Ward, M.S., Fortheringham, A.K., Cooper, M.E., Forbes, J.M., Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease. Current Opinion in Pharmacology 13 (2013), 654–661.
167. Xie, Z., Smith, C.J., Van Eldik, L.J., Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38. Glia 45 (2004), 170–179.
168. Xiong, X.Y., Liu, L., Yang, Q.W., Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke. Progress in Neurobiology 142 (2016), 23–44.
169. Xu, K., Geczy, C.L., IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. Journal of Immunology 164 (2000), 4916–4923.
170. Xu, K., Yen, T., Geczy, C.L., IL-10 up-regulates macrophage expression of the S100 protein S100A8. Journal of Immunology 166 (2001), 6358–6366.
171. Yamagishi, S., Matsui, T., Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxidative Medicine and Cellular Longevity 3 (2010), 101–108.
172. Yamagishi, S., Nakamura, K., Matsui, T., Takeuchi, M., Minodronate, a nitrogen-containing bisphosphonate, is a promising remedy for treating patients with diabetic retinopathy. Medical Hypotheses 66 (2006), 273–275.
173. Yammani, R.R., Long, D., Loeser, R.F., Loeser interleukin-7 stimulates secretion of S100A4 by activating the JAK-STAT signaling pathway in human articular chondrocytes. Arthritis and Rheumatism 60 (2009), 792–800.
174. Yan, S.F., D'Agati, V., Schmidt, A.M., Ramasamy, R., Receptor for advanced glycation end products (RAGE): A formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Current Molecular Medicine 7 (2007), 699–710.
175. Ye, C., Choi, J.G., Abraham, S., Wu, H., Diaz, D., Terreros, D., et al. Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proceedings of the National Academy of Sciences of the United States of America 109 (2012), 21052–21057.
176. Yoo, Y., Byun, K., Kang, T., Bayarsaikhan, D., Kim, J.Y., Oh, S., et al. Amyloid-beta-activated human microglial cells through ER-resident proteins. Journal of Proteome Research 14 (2015), 214–223.
177. Yoshida, T., Yamagishi, S., Nakamura, K., Matsui, T., Imaizumi, T., Takeuchi, M., et al. Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia 49 (2006), 3094–3099.
178. Zafar, H., Inhibition of protein glycation and advanced glycation end products by ascorbic acid. African Journal of Biotechnology, 11, 2012, 51.
179. Zeng, S., Dun, H., Ippagunta, N., Rosario, R., Zhang, Q.Y., Lefkowitch, J., et al. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. Journal of Hepatology 50 (2009), 929–936.
180. Zetterström, C.K., Jiang, W., Wähämaa, H., Ostberg, T., Aveberger, A.C., Schierbeck, H., et al. Pivotal advance: Inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate. Journal of Leukocyte Biology 83 (2008), 31–38.
181. Zhang, Z., Zhang, L., Zhou, C., Wu, H., Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo. International Immunopharmacology 23 (2014), 14–26.
182. Zhou, H., Ji, X., Wu, Y., Xuan, J., Qi, Z., Shen, L., et al. A dual-role of Gu-4 in suppressing HMGB1 secretion and blocking HMGB1 pro-inflammatory activity during inflammation. PloS One, 9, 2014, e89634.
183. Zhou, Y., Wang, Y., Kovacs, M., Jin, J., Zhang, J., Microglial activation induced by neurodegeneration: A proteomic analysis. Molecular & Cellular Proteomics 4 (2005), 1471–1479.
184. Zhu, Y., Chen, X., Pan, Q., Wang, Y., Su, S., Jiang, C., et al. A comprehensive proteomics analysis reveals a secretory path-and status-dependent signature of exosomes released from tumor-associated macrophages. Journal of Proteome Research 14 (2015), 4319–4331.
185. Zhu, X., Raina, A.K., Lee, H.G., Casadesus, G., Smith, M.A., Perry, G., Oxidative stress signalling in Alzheimer's disease. Brain Research 1000 (2004), 32–39.
186. Zhu, T., Wang, D.X., Zhang, W., Liao, X.Q., Guan, X., Bo, H., et al. Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB. PloS One, 8, 2013, e56407.
187. Ziskoven, C., Jäger, M., Zilkens, C., Bloch, W., Brixius, K., Krauspe, R., Oxidative stress in secondary osteoarthritis: From cartilage destruction to clinical presentation?. Orthopedic Reviews (Pavia), 2, 2010, e23.